127 related articles for article (PubMed ID: 36184379)
1. Tracking Docetaxel-Induced Cellular Proliferation Changes in Prostate Tumor-Bearing Mice with
Jadvar H; Park R; Vorobyova I; Chen K
Acad Radiol; 2023 Aug; 30(8):1721-1726. PubMed ID: 36184379
[TBL] [Abstract][Full Text] [Related]
2. [18F]-2'-Fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in prostate cancer: initial preclinical observations.
Jadvar H; Yap LP; Park R; Li Z; Chen K; Hughes L; Kouhi A; Conti P
Mol Imaging; 2012; 11(5):426-32. PubMed ID: 22954187
[TBL] [Abstract][Full Text] [Related]
3. Early response assessment in prostate carcinoma by ¹⁸F-fluorothymidine following anticancer therapy with docetaxel using preclinical tumour models.
Oyama N; Hasegawa Y; Kiyono Y; Kobayashi M; Fujibayashi Y; Ponde DE; Dence C; Welch MJ; Yokoyama O
Eur J Nucl Med Mol Imaging; 2011 Jan; 38(1):81-9. PubMed ID: 20878403
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. Monitoring tumor response with [18F]FMAU in a sarcoma-bearing mouse model after liposomal vinorelbine treatment.
Chan PC; Wu CY; Chang WT; Lin CY; Tseng YL; Liu RS; Alauddin MM; Lin WJ; Wang HE
Nucl Med Biol; 2013 Nov; 40(8):1035-42. PubMed ID: 23969084
[TBL] [Abstract][Full Text] [Related]
6. Sex as a Biologic Variable in Preclinical Imaging Research: Initial Observations with
Chan SR; Salem K; Jeffery J; Powers GL; Yan Y; Shoghi KI; Mahajan AM; Fowler AM
J Nucl Med; 2018 May; 59(5):833-838. PubMed ID: 29217733
[TBL] [Abstract][Full Text] [Related]
7. [11C]Choline as pharmacodynamic marker for therapy response assessment in a prostate cancer xenograft model.
Krause BJ; Souvatzoglou M; Herrmann K; Weber AW; Schuster T; Buck AK; Nawroth R; Weirich G; Treiber U; Wester HJ; Ziegler SI; Senekowitsch-Schmidtke R; Schwaiger M
Eur J Nucl Med Mol Imaging; 2010 Oct; 37(10):1861-8. PubMed ID: 20512572
[TBL] [Abstract][Full Text] [Related]
8. A Pilot Trial Evaluating Zoledronic Acid Induced Changes in [
Vaishampayan UN; Tehrani OS; Lawhorn-Crews JM; Heilbrun LK; Dobson K; Smith D; Dickow B; Shields AF
Mol Imaging Biol; 2017 Dec; 19(6):810-816. PubMed ID: 28289967
[TBL] [Abstract][Full Text] [Related]
9. Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xenografts.
Schroeder RP; van Weerden WM; Krenning EP; Bangma CH; Berndsen S; Grievink-de Ligt CH; Groen HC; Reneman S; de Blois E; Breeman WA; de Jong M
Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1257-66. PubMed ID: 21431398
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and fluorine-18 radiolabeling of a phospholipid as a PET imaging agent for prostate cancer.
Kwan KH; Burvenich IJG; Centenera MM; Goh YW; Rigopoulos A; Dehairs J; Swinnen JV; Raj GV; Hoy AJ; Butler LM; Scott AM; White JM; Ackermann U
Nucl Med Biol; 2021 Feb; 93():37-45. PubMed ID: 33310350
[TBL] [Abstract][Full Text] [Related]
11. Assessment of PET tracer uptake in hormone-independent and hormone-dependent xenograft prostate cancer mouse models.
Kukuk D; Reischl G; Raguin O; Wiehr S; Judenhofer MS; Calaminus C; Honndorf VS; Quintanilla-Martinez L; Schönberger T; Duchamp O; Machulla HJ; Pichler BJ
J Nucl Med; 2011 Oct; 52(10):1654-63. PubMed ID: 21859811
[TBL] [Abstract][Full Text] [Related]
12. Comparison of [(11)C]Choline ([(11)C]CHO) and [(18)F]Bombesin (BAY 86-4367) as Imaging Probes for Prostate Cancer in a PC-3 Prostate Cancer Xenograft Model.
Schwarzenböck SM; Schmeja P; Kurth J; Souvatzoglou M; Nawroth R; Treiber U; Kundt G; Berndt S; Graham K; Senekowitsch-Schmidtke R; Schwaiger M; Ziegler SI; Dinkelborg L; Wester HJ; Krause BJ
Mol Imaging Biol; 2016 Jun; 18(3):393-401. PubMed ID: 26483088
[TBL] [Abstract][Full Text] [Related]
13. Effect of Androgen on Normal Biodistribution of [
Jadvar H; Park R; Yap LP; Chen K; Hughes L; Conti P
Anticancer Res; 2017 Feb; 37(2):475-479. PubMed ID: 28179292
[TBL] [Abstract][Full Text] [Related]
14. ATM/NEMO signaling modulates the expression of PD-L1 following docetaxel chemotherapy in prostate cancer.
Wang Z; Zhang X; Li W; Su Q; Huang Z; Zhang X; Chen H; Mo C; Huang B; Ou W; Chen J; Zhao G; Chen L; Shao L
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34301812
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of 3'-deoxy-3'-18F-fluorothymidine uptake to cell proliferation in lung carcinoma xenografts].
Liu X; Zhou NK; Zhang JM; Liang ZY; Zheng X
Ai Zheng; 2006 Dec; 25(12):1512-6. PubMed ID: 17166377
[TBL] [Abstract][Full Text] [Related]
16. Reduced 64Cu uptake and tumor growth inhibition by knockdown of human copper transporter 1 in xenograft mouse model of prostate cancer.
Cai H; Wu JS; Muzik O; Hsieh JT; Lee RJ; Peng F
J Nucl Med; 2014 Apr; 55(4):622-8. PubMed ID: 24639459
[TBL] [Abstract][Full Text] [Related]
17. TGF-β causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization.
Li Y; Zhang B; Xiang L; Xia S; Kucuk O; Deng X; Boise LH; Dong JT
Theranostics; 2020; 10(17):7656-7670. PubMed ID: 32685011
[TBL] [Abstract][Full Text] [Related]
18. PET imaging of VPAC1 expression in experimental and spontaneous prostate cancer.
Zhang K; Aruva MR; Shanthly N; Cardi CA; Rattan S; Patel C; Kim C; McCue PA; Wickstrom E; Thakur ML
J Nucl Med; 2008 Jan; 49(1):112-21. PubMed ID: 18077536
[TBL] [Abstract][Full Text] [Related]
19. Effective photothermal chemotherapy with docetaxel-loaded gold nanospheres in advanced prostate cancer.
Shen Y; Ma Z; Chen F; Dong Q; Hu Q; Bai L; Chen J
J Drug Target; 2015; 23(6):568-76. PubMed ID: 25738990
[TBL] [Abstract][Full Text] [Related]
20. Docetaxel-titanate nanotubes enhance radiosensitivity in an androgen-independent prostate cancer model.
Mirjolet C; Boudon J; Loiseau A; Chevrier S; Boidot R; Oudot A; Collin B; Martin E; Joy PA; Millot N; Créhange G
Int J Nanomedicine; 2017; 12():6357-6364. PubMed ID: 28919739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
